Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(38:4) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 644 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 771 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 723 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 481 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 393 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 533 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 472 | pmol/sample |
| - | PE(38:4) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 706 | pmol/sample |
| - | PE(38:4) | C | 0.0 | BCD100427B001 | 1092 | pmol/sample |
| - | PE(38:4) | C | 0.5 | BCD100427B003 | 580 | pmol/sample |
| - | PE(38:4) | C | 1.0 | BCD100427B007 | 1118 | pmol/sample |
| - | PE(38:4) | C | 2.0 | BCD100427B011 | 506 | pmol/sample |
| - | PE(38:4) | C | 4.0 | BCD100427B015 | 551 | pmol/sample |
| - | PE(38:4) | C | 8.0 | BCD100427B019 | 433 | pmol/sample |
| - | PE(38:4) | C | 12.0 | BCD100427B023 | 453 | pmol/sample |
| - | PE(38:4) | C | 24.0 | BCD100427B027 | 604 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 471 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 478 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 431 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 406 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 503 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 388 | pmol/sample |
| - | PE(38:4) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 964 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 0.5 | BCD100427B004 | 1073 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 1.0 | BCD100427B008 | 513 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 2.0 | BCD100427B012 | 1087 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 4.0 | BCD100427B016 | 566 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 8.0 | BCD100427B020 | 704 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 12.0 | BCD100427B024 | 647 | pmol/sample |
| - | PE(38:4) | 25OH-Chol | 24.0 | BCD100427B028 | 585 | pmol/sample |